Therapeutic Asset Ratings

311 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Carboplatin Homologous Recombination Deficiency	University of Washington	P2	B (60)
cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine HER2 Negative Breast Carcinoma	University of Washington	P2	B (60)
Cladribine Myeloid Sarcoma	University of Washington	P2	B (60)
Cyclophosphamide Recurrent B Lymphoblastic Lymphoma	University of Washington	P2	B (60)
Cyclophosphamide Refractory B Lymphoblastic Lymphoma	University of Washington	P2	B (60)
Decitabine Essential Thrombocythemia	University of Washington	P2	B (60)
Decitabine Polycythemia Vera	University of Washington	P2	B (60)
Decitabine Primary Myelofibrosis	University of Washington	P2	B (60)
DEXAMETHASONE EBV-Positive DLBCL, Nos	University of Washington	P2	B (60)
DEXAMETHASONE Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma	University of Washington	P2	B (60)
Eloxatin Gray-Zone Lymphoma	University of Washington	P2	B (60)
FLUDEOXYGLUCOSE High Grade B-Cell Lymphoma	University of Washington	P2	B (60)
FLUTICASONE Triple-Negative Breast Carcinoma	University of Washington	P2	B (60)
Inno-206 High-grade B-cell Lymphoma	University of Washington	P2	B (60)
Inotuzumab Ozogamicin Recurrent B Lymphoblastic Lymphoma	University of Washington	P2	B (60)
Inotuzumab Ozogamicin Refractory B Lymphoblastic Lymphoma	University of Washington	P2	B (60)
Mitoxantrone Mixed Phenotype Acute Leukemia	University of Washington	P2	B (60)
PEGFILGRASTIM Recurrent Adult Lymphoblastic Lymphoma	University of Washington	P2	B (60)
PEGFILGRASTIM Recurrent T Acute Lymphoblastic Leukemia	University of Washington	P2	B (60)
Pumvc3-Igfbp2-Her2-Igf1R Plasmid Dna Vaccine Anatomic Stage I Breast Cancer AJCC v8	University of Washington	P2	B (60)
SRY-BOX TRANSCRIPTION FACTOR 2 HER2 Negative Breast Carcinoma	University of Washington	P2	B (60)
Yb-1 HER2 Negative Breast Carcinoma	University of Washington	P2	B (60)
Recombinant Human Hyaluronidase Diffuse Large B-Cell Lymphoma	University of Washington	P2/3	B (60)
Imatinib T Acute Lymphoblastic Leukemia	University of Washington	P3	B (59)
Mosunetuzumab Marginal Zone Lymphoma	University of Washington	P3	B (59)

Showing 101 to 125 of 311 assets

PreviousPage 5 of 13Next